ALX Oncology Holdings Inc.
ALXO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $87 | $640 | $459 | $866 |
| - Cash | $18 | $22 | $49 | $364 |
| + Debt | $17 | $17 | $10 | $1 |
| Enterprise Value | $87 | $635 | $420 | $503 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$132 | -$158 | -$123 | -$83 |
| % Margin | – | – | – | – |
| Net Income | -$135 | -$161 | -$123 | -$83 |
| % Margin | – | – | – | – |
| EPS Diluted | -2.58 | -3.74 | -3.03 | -2.07 |
| % Growth | 31% | -23.4% | -46.4% | – |
| Operating Cash Flow | -$122 | -$130 | -$89 | -$68 |
| Capital Expenditures | -$0 | -$1 | -$1 | -$5 |
| Free Cash Flow | -$122 | -$132 | -$91 | -$73 |